Miscellaneous / HotStarTaq Plus DNA Polymerase

This is a combined Synopsis/Solicitation/Request for Quote for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued for the solicitation number NIAID-RFQ-13C-1637295, a Request for Quote. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2005-69 dated August 1, 2013. This acquisition will be processed under Simplified Acquisition Procedures (SAP) and is not a small business set-aside, however small disadvantage, minority, veteran owned and HUB zone companies are encourage in submitting a proposal. The associated North American Industry Classification System (NAICS) Code is 325199, which has a business size standard of 1000. The National Institute of Allergy and Infectious Diseases (NIAID) intends to procure HotStarTaq DNA Polymerase a standing order. Item/Description/Quantity: 1) HotStarTaq Plus DNA Polymerase (25000), Cat # 203609, qty-6 each. The HotStarTaq has been used by the lab for over a year as is critical component to support various protocols in the development of vaccines for HIV and other viral diseases. The continuity of the DNA polymerase must be maintained to ensure experimental results are not influence by other variables. This is a standing order that will be requested and shipped as needed to Bethesda, Maryland 20892. The following factors shall be used to evaluate offers: 1) capability to meet specifications, 2) price and 3) delivery (standing order for one (1) year from date of award). The government will award a fixed price purchase order to the responsible contractor. The FOB terms are "Destination" and Net 30. The following Federal Acquisition Regulations provisions and clauses apply to the acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items; Far 52.212-2 Evaluation Commercial Items; Far 52.212-3 Offeror Representation and Certifications Commercial Items; Far 52.212-4 Contract Terms and Conditions Commercial Items; Far 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items; and FAR 52.232-33, Payment by Electronic Funds Transfer-Central Contractor Registration (Oct 2003). A completed copy of provisions at FAR 52.212-3 Offerors Representation and Certifications Commercial Items must be included which can be found online at System for Award Management (SAM) https://www.sam.gov. By submission of an offer, the Offeror acknowledges the requirement that a prospective awardee shall be registered in the SAM database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation. [Note: Lack of registration in SAM will make an Offeror ineligible for award.] All responsible sources may submit an offer that will be considered by the Agency. Offers must be submitted by 5:00 P.M. Eastern Daylight Savings Time on Tuesday, September 3, 2013 through the U.S. Postal Service at the address of NIH/NIAID/AMOB, 10401 Fernwood Road, Room 2NE38B, MSC 4811, Bethesda, Maryland 20892-4811. E-mail and Fax submissions are not authorized. Request for information concerning this requirement are to be submitted in writing and can be faxed to 301-480-8720 or e-mail to battleja@niaid.nih.gov. It is the vendor's responsibility to confirm receipts of all quotations and/or questions by the closing date of this announcement by contacting Janice Battle at (301) 402-2282. Collect calls will not be accepted.